Fed Circuit refuses to hear $23m Medtronic loss
30-04-2019
Capricor acquires Medtronic patents to boost heart failure treatments
15-10-2014
JHVEphoto / Shutterstock.com
The US Patent Trial and Appeal Board (PTAB) has confirmed the validity of three remaining Medtronic patents challenged by rival medical device manufacturer Axonics.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Medtronic, Axonics, PTAB, InterSim, PTAB, US District Court for the Central District of California
